Total Payments
$2,132
2024 Payments
$591.67
Companies
26
Transactions
105
Medicare Patients
1,059
Medicare Billing
$139,196
Payment Breakdown by Category
Food & Beverage$2,132 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,132 | 105 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $471.17 | 30 | $0 (2024) |
| Lilly USA, LLC | $276.71 | 14 | $0 (2024) |
| Amgen Inc. | $208.02 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $190.34 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $161.13 | 5 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $100.13 | 4 | $0 (2021) |
| AbbVie Inc. | $94.54 | 4 | $0 (2023) |
| PFIZER INC. | $65.36 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $64.69 | 4 | $0 (2024) |
| Corcept Therapeutics | $59.57 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $591.67 | 31 | Novo Nordisk Inc ($181.80) |
| 2023 | $686.03 | 28 | GlaxoSmithKline, LLC. ($139.19) |
| 2022 | $503.66 | 27 | Lilly USA, LLC ($165.10) |
| 2021 | $350.44 | 19 | Paratek Pharmaceuticals, Inc. ($100.13) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Diagnostics | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Obesity | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Inflammation | ||||||
| 07/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: DIABETES | ||||||
| 04/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Endocrinology | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Cardiology | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Biological | ||||||
| 03/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Obesity | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Obesity | ||||||
| 02/20/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 230 | 404 | $55,385 | $23,587 |
| 2022 | 5 | 262 | 499 | $80,715 | $37,156 |
| 2021 | 5 | 288 | 512 | $83,450 | $44,100 |
| 2020 | 5 | 279 | 578 | $87,245 | $34,353 |
Total Patients
1,059
Total Services
1,993
Medicare Billing
$139,196
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 193 | $25,090 | $10,898 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 124 | $21,700 | $7,567 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 15 | $3,000 | $1,803 | 60.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 39 | $3,120 | $1,656 | 53.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 19 | $1,425 | $1,357 | 95.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 12 | 14 | $1,050 | $305.79 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 316 | $55,300 | $24,117 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 95 | $12,350 | $5,934 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 59 | $11,800 | $5,931 | 50.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $975.00 | $891.02 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 16 | $290.00 | $284.20 | 98.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 277 | $48,475 | $23,612 | 48.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 96 | 142 | $28,400 | $16,499 | 58.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 32 | $4,160 | $1,822 | 43.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $1,875 | $1,627 | 86.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 36 | 36 | $540.00 | $540.00 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 123 | 326 | $57,050 | $21,521 | 37.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 185 | $24,050 | $8,966 | 37.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 20 | $4,000 | $2,076 | 51.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 23 | 24 | $1,800 | $1,445 | 80.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 23 | 23 | $345.00 | $344.40 | 99.8% |
About Monisola Adeyemo, N.P
Monisola Adeyemo, N.P is a Clinic/Center healthcare provider based in Largo, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881754349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Monisola Adeyemo, N.P has received a total of $2,132 in payments from pharmaceutical and medical device companies, with $591.67 received in 2024. These payments were reported across 105 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,132).
As a Medicare-enrolled provider, Adeyemo has provided services to 1,059 Medicare beneficiaries, totaling 1,993 services with total Medicare billing of $139,196. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinic/Center
- Other Specialties Family Medicine
- Location Largo, MD
- Active Since 12/12/2006
- Last Updated 01/23/2018
- Taxonomy Code 261Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881754349
Products in Payments
- Ozempic (Drug) $254.70
- MOUNJARO (Drug) $150.05
- Otezla (Drug) $126.18
- NUZYRA (Drug) $100.13
- AREXVY (Drug) $96.75
- Rybelsus (Drug) $90.41
- Repatha (Biological) $81.84
- UBRELVY (Drug) $73.83
- BREZTRI (Drug) $71.52
- TRULICITY (Drug) $68.64
- SHINGRIX (Biological) $64.38
- Korlym (Drug) $59.57
- FARXIGA (Drug) $58.79
- EMGALITY (Drug) $58.02
- Cologuard Collection Kit (Device) $53.24
- HETLIOZ (Drug) $49.58
- PREVNAR 20 (Biological) $49.47
- Wegovy (Drug) $48.32
- ENTRESTO (Drug) $47.52
- PENNSAID (Drug) $46.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.